Lyn Fitzgerald

In her new role, Fitzgerald will build collaborations with life sciences companies to help advance innovation, improve outcomes and deliver quality oncology patient care, all consistent with McKesson’s increasing strategic focus on oncology.

Fitzgerald has more than 25 years of experience in healthcare. She spent more than 13 years in oncology at the National Comprehensive Cancer Network (NCCN), where she most recently served as Senior Vice President, U.S. & Global Development. In this role, Fitzgerald was responsible for the development of U.S. and International business strategies for the optimization of brand relevance, influence and the overall financial sustainability of the NCCN organization. During her tenure, Fitzgerald drove the development and successful execution of an innovative business and significantly expanded the reach and utilization of NCCN content across the entire oncology ecosystem. Serving as a key stakeholder for industry, she was responsible for the U.S. & Global Corporate Council, which included biopharmaceutical and medical device manufacturers as well as all commercial permissions and licensing. Lyn was also instrumental in the launch of the NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business.